💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Intra-Cellular Therapies Inc. (ITCI)
« Back to company indexITCI Chatter Timeline
Stock Ticker for ITCI
Most Active Tweeters for ITCI
| User | Tweets |
|---|---|
| @HealthcareBeat | 10 |
| @Tickeron | 9 |
| @dispatchtribune | 7 |
| @gcassidy718 | 7 |
| @dakotafinancial | 6 |
Recent Tweets for ITCI
 |
@gcassidy718 $ITCI waiting for the turn around . . . -3.89 % change recently https://t.co/pg77CdHU2e 7:07pm |
 |
@BlueBioNow $ITCI good earnings are hopefully coming next quarter -3.89 % change recently https://t.co/fSwQakjS1N 1:07pm |
|
@BlueBioNow $ITCI "Everything is impossible until someone does it" -3.89 % change recently https://t.co/fSwQakjS1N 1:07am |
|
@gcassidy718 $ITCI Valuation is starting to make more sense now $21.79. https://t.co/pg77CdHU2e 12:07am |
 |
@InsiderAlerts4U $ITCI: New Insider Filing on Intra-Cellular Therapies, Inc.'s Director RORY B RIGGS: https://t.co/13JIekd67s July 3rd 2020, 7:07pm |
 |
@Tickeron $ITCI in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/49WQveyuap July 3rd 2020, 6:07pm |
|
@BlueBioNow $ITCI a bit volatility -3.89 % change recently https://t.co/fSwQakjS1N July 3rd 2020, 2:07pm |
|
@gcassidy718 $ITCI I'd like to make an exit, just not now -3.89 % change recently https://t.co/pg77CdHU2e July 3rd 2020, 5:07am |
 |
@HealthcareBeat $15,735.71 of shares acquired by Alafi Christopher D (Director), reported in a new form 4 filed with the SEC $ITCI https://t.co/1Pqq0o5ME7 July 3rd 2020, 1:07am |
|
@InsiderAlerts4U $ITCI: New Insider Filing on Intra-Cellular Therapies, Inc.'s Director CHRISTOPHER D ALAFI: https://t.co/fdQ2pK32N7 July 3rd 2020, 1:07am |
|
@HealthcareBeat $15,735.71 of shares acquired by Riggs Rory B (Director), reported in a new form 4 filed with the SEC $ITCI https://t.co/mxGnsMZOKX July 3rd 2020, 12:07am |
|
@HealthcareBeat $14,991.28 of shares acquired by Lerner Richard A (Director), reported in a new form 4 filed with the SEC $ITCI https://t.co/KKQezkppvR July 3rd 2020, 12:07am |
|
@HealthcareBeat $7,059.25 of shares acquired by Van Nostrand Robert L (Director), reported in a new form 4 filed with the SEC $ITCI https://t.co/uu5utrXKLb July 3rd 2020, 12:07am |
|
@InsiderAlerts4U $ITCI: New Insider Filing on Intra-Cellular Therapies, Inc.'s Director RICHARD A LERNER: https://t.co/SRXgmaZXnF July 2nd 2020, 9:07pm |
|
@Tickeron $ITCI in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/t9PWwxNZA0 July 2nd 2020, 4:07pm |
 |
@deus_trader Optimus Maximus v2 2020-07-02 16:01 ET. *Closed/Covered previously shorted: $ITCI at $24.23 for 0.90 profit (3.58%)… https://t.co/r7LhT4kiOC July 2nd 2020, 4:07pm |
|
@Tickeron $ITCI in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/M0zrEmPICO July 1st 2020, 4:07pm |
|
@deus_trader Optimus Maximus v2 2020-07-01 09:32 ET. *Closed/Covered previously shorted: $ITCI at $25.19 for 0.25 loss (-1.02%).… https://t.co/Vx7Je5JYcA July 1st 2020, 9:07am |
 |
@EnterpriseLeade Intra-Cellular Therapies Inc $ITCI Expected to Post Earnings of -$0.98 Per Share https://t.co/D8hJZHoPma July 1st 2020, 7:07am |
 |
@dailypoliticaln Intra-Cellular Therapies Inc $ITCI Expected to Post Earnings of -$0.98 Per Share https://t.co/va3QON97Vn July 1st 2020, 7:07am |
 |
@ZolmaxNews Intra-Cellular Therapies Inc $ITCI Expected to Post Earnings of -$0.98 Per Share https://t.co/Sq2fCPPi93 July 1st 2020, 7:07am |
 |
@GiovanniMotta2 $ITCI should go to 30+$ in the next few weeks considering also Intra-Cellular Therapies Announces Positive Top-line… https://t.co/CTx5hdNvIW July 1st 2020, 6:07am |
|
@deus_trader Optimus Maximus v2 2020-06-30 10:29 ET. Shorted/Opened: $ITCI at $25.00. Intra-Cellular Therapies, Inc (CORP). Win… https://t.co/55VlDLz3vJ June 30th 2020, 10:06am |
|
@deus_trader Optimus Maximus v2 2020-06-30 10:01 ET. Shorted/Opened: $ITCI at $25.20. Intra-Cellular Therapies, Inc (CORP). Win… https://t.co/cAxZ3UxEU2 June 30th 2020, 10:06am |
|
@dailypoliticaln Brokerages Expect Intra-Cellular Therapies Inc $ITCI Will Announce Quarterly Sales of $3.10 Million https://t.co/2KhaYzI5Lj June 30th 2020, 2:06am |
|
@ZolmaxNews Intra-Cellular Therapies Inc $ITCI Expected to Announce Quarterly Sales of $3.10 Million https://t.co/It18YbS9t2 June 30th 2020, 2:06am |
|
@gcassidy718 $ITCI That's rough. . . -2.53 % change recently https://t.co/pg77CdHU2e June 30th 2020, 1:06am |
 |
@Gambiste1 RT @MaisaCorp: $ITCI its phase 1/2 study on novel inhibitor ITI-214-104 for the treatment of patients with chronic systolic heart failure w… June 29th 2020, 7:06pm |
|
@Gambiste1 RT @syinvesting: $ITCI Intra-Cellular Therapies announced positive topline Phase 1/2 SAD data from ITI-214 (PDE1 inhibitor) in patients wit… June 29th 2020, 7:06pm |
 |
@MaisaCorp $ITCI its phase 1/2 study on novel inhibitor ITI-214-104 for the treatment of patients with chronic systolic heart… https://t.co/xdOJKGdaYl June 29th 2020, 4:06pm |
 |
@syinvesting $ITCI Intra-Cellular Therapies announced positive topline Phase 1/2 SAD data from ITI-214 (PDE1 inhibitor) in patie… https://t.co/lqwZwkt0nJ June 29th 2020, 3:06pm |
 |
@bucksneuro RT @BillMiller32: @alsterbrown Thanks! I added on the brief sub-$25 pull-back here $ITCI June 29th 2020, 12:06pm |
 |
@SlingshotCtlyst Top-line Results from $ITCI ITI-214 Phase I/II Study in Patients with Heart Failure available here: https://t.co/QGAYCCXsUB June 29th 2020, 10:06am |
 |
@BillMiller32 @alsterbrown Thanks! I added on the brief sub-$25 pull-back here $ITCI June 29th 2020, 10:06am |
 |
@Briefingcom $ITCI: Intra-Cellular Therapies announced topline results from Study ITI-214-104, a Phase I/II translational study.… https://t.co/HOAw7hpHPN June 29th 2020, 10:06am |
|
@bucksneuro RT @BillMiller32: $ITCI Beyond Schizophrenia & Bipolar II(Coming up v.soon), another big positive Top-Line in the Tx of Heart Failure Pts (… June 29th 2020, 9:06am |
 |
@SEC_Filings_Now $ITCI: New SEC Filing for $ITCI: Form 8-K (No. 0000950123-20-006465): https://t.co/7XjcEHiWt2 June 29th 2020, 9:06am |
 |
@bbiittccooiinn $ITCI #NASDAQ 8-K - Intra-Cellular Therapies, Inc. [B/A=0/0 - Bid/Ask Size=0/0 Volume=1,161,970 AverageVol=971,… https://t.co/yIxnRiMJRw June 29th 2020, 9:06am |
 |
@SwingTradeBot Recent $ITCI technical alerts: New Uptrend plus 3 more alerts... https://t.co/xs6K8oSF6z June 29th 2020, 9:06am |
 |
@MarketCurrents $ITCI - Intra-Cellular's ITI-214 shows positive action in heart failure study https://t.co/BLW29MmOdA June 29th 2020, 8:06am |
 |
@Avecousans_TVA RT @BioStocks: $ITCI Announces Positive Top-line Results from ITI-214 Phase I/II Study in Patients with Heart Failure June 29th 2020, 8:06am |
|
@BillMiller32 $ITCI Beyond Schizophrenia & Bipolar II(Coming up v.soon), another big positive Top-Line in the Tx of Heart Failure… https://t.co/8HdeECmP4N June 29th 2020, 8:06am |
 |
@BleugoIG $ITCI loving my August $45 covered calls. June 29th 2020, 8:06am |
 |
@FlexOniHub $ITCI Wow! Huge Results were Positive! Things are gonna explode there today! all,imo @FlexOniHub June 29th 2020, 8:06am |
 |
@Quantumup1 RT @portefeuillefun: $ITCI. Intra-Cellular Therapies Announces Positive Top-line Results from ITI-214 Phase I/II Study in Patients with Hea… June 29th 2020, 8:06am |
 |
@sbwcws Intra-Cellular announces top-line results from ITI-214 Phase I/II study $ITCI June 29th 2020, 8:06am |
 |
@portefeuillefun $ITCI. Intra-Cellular Therapies Announces Positive Top-line Results from ITI-214 Phase I/II Study in Patients with… https://t.co/dduP7LlkMM June 29th 2020, 8:06am |
 |
@BioStocks $ITCI Announces Positive Top-line Results from ITI-214 Phase I/II Study in Patients with Heart Failure June 29th 2020, 8:06am |
 |
@GrnBulls This Week in BioTech: $ITCI is scheduled to release top-line results from Phase 1/2 clinical trial of ITI-214, it… https://t.co/9OZq2P9M2F June 29th 2020, 6:06am |
 |
@WeekHerald Intra-Cellular Therapies $ITCI Rating Lowered to Hold at Zacks Investment Research https://t.co/IROb8734Bq June 29th 2020, 2:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
